Table: begin end state 1 25 cytoplasmic 26 52 transmembrane 53 59 non-cytoplasmic 60 84 transmembrane 85 95 cytoplasmic 96 114 transmembrane 115 119 non-cytoplasmic 120 141 transmembrane 142 161 cytoplasmic 162 184 transmembrane 185 195 non-cytoplasmic 196 215 transmembrane 216 245 cytoplasmic 246 265 transmembrane 266 279 non-cytoplasmic 280 304 transmembrane 305 310 cytoplasmic 311 331 transmembrane 332 338 non-cytoplasmic 339 363 transmembrane 364 374 cytoplasmic 375 397 transmembrane 398 407 non-cytoplasmic 408 425 transmembrane 426 448 cytoplasmic
Input: >AO353_15110 MPVQPLTRPDPARDTPTPGAGKKSIFAVVLGNAVEFFDFGVYATFAVMIGHTFFPSDSAF VSLMLSVIAFGTGFIVRPLGAVLIGAYADRVGRKPAMLLTLVMMAVGTGSIAILPGYETI GIAAPILLVVTRMIQGLAWGGEAGPATTYILEAAPPHKRGTYACWQVVAQGVAAMVAGLV GFTLTKVLSPEDLNSWGWRVPFVFGLLVLPIGIYIRRNLAETFHGHTEQTRTGDLVREIV GKHRRALVLGLLILSGSTITQYFLNYMTTFALTELKLPTSIAMLSTLVAGAAMAVCAVAG GMLCDRFGRRVILMTPRVVLLLILFPALQLMTEHPSSATFLLTLAVLSGLHGMSGAALIV LLVESFPKSVRATGFSIVYAFGVAAFGGTAQIIITWLIGTTGDPMSPVWYLLIANLVCLT AAWFAKETRPLLPERPARETRLAEAQVH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server